Read i bc27f85be50b71b1 Online
Authors: Unknown
tNDEX 949
Hyperplasia, 3 n
Hypoxemia, 130, 770
Hyperpnea, lOOt
oxygen therapy in, 770-783
Hypersensitivity
signs and symptoms of. I I I t
and aller�K reactions. See Allergic
Hypoxia, 113, 130
reaction!>
sensory. after ampuratlon, 894t
Ifosfamide, 855t
I lypertension, 392-395
lIeo!ltomy, 549
hlood pressure r,ln�e m. 19t
Ileum
drug therapy Ill, 60-61. 393
111 bladder substitution procedure,
�-adrener�ic blockers Ill, 853t
599
calcIUm t:hanncl blockers m,
Crohn's disease of, 537
854t
function of, 504t
dIUretics 111, 861,
Ileostomy of, 549
vasodilators Ill, 869t
Ileus, paralytic, 532
effcct!> on tMget organ!>, 392, 394t
Iliohypogastric nerve, 279t
kidney disorder!> Ill. 394t, 572
iliOingUinal nerve. 279r
111 pheochromocytoma. 39.5t, 673
Ilium, fractures of, 174, 175f
portal. 542
Immobilization
esopbagc'll varices m, 526
braces, splints, and orthoses m, 225-
hepatiC enccphalop;uhy Ill, 544
229
III liver failure. 7141
casts m, 220-224
poslllolllng prc�autlons Ill, 551
and effects of prolonged bed rest,
pulmon,uy, III I flV IIlfc�tlon and
752-753, 754t
AIDS, 63lt
of knee, 227t
risk factors for, .192-39.,
m hip arthroplasty. 195
secondary, .,93, 395t
m knee arthroplasty, 200, 20 I , 209
II}'pcrthyroidism, 656-658, 657t, 660
Immune system, 606, 607r
Hypertonicity of muscle!>, 295-296
components of, 606, 608r
Hypertrophy of pro!>tate. benign. S84-
factors affectmg, 606, 609t
586, 196
in re,ectlon of organ transplantation,
Hypcrvcnlilanon, lOOt
702-707
H)·pcrvolenua. 764, 76S(
Immunocompronllsed patients, 607r
I lypodcrmis, 4,�8t
ImmunodefiCiency virus infection,
11)'I>oglo!>sal nervc. 2921
human, 631-634. See also
llypoglyccnlla III diabetes melhrus, 677,
HIV mfection and AIDS
685
Immunoglobulm IgA nephropathy, 574-
Ilypoglycenlic agent!!. oral. III diabetes
575
mellnu!>. 678
Immunosuppression, 607,
766t
111 transplantation procedures, 703
Hyponatremia. 76.5t
and acutc relcction, 706
Hypoparathyroldl!im, 688-689
In bone marrow transplantation,
HYPOpituitarism, 666-667
734
Hypotension. orthostatic
and chrolllc relectlon, 706-707
in heart transplantallOn, 726
drugs used 111, 704t-705t
111 IIlfectlon!!, 639-640
infections m, 707-708
l lypOlh.ll.1nlll!o
Immunotherapy in cancer, 343, 344
and pituitary flillCtlOn, 660, 663
Impedance plethysmography, 373t
strULture and function of, 265t
Incontinence
Ilypothyroidlsm, 658-660
fecal, III cancer, 349
Ilyporomclt)" of muscles, 295-296
urmary, 562, 584, 585(
Hypoventllalion, lOOt
bladder neck suspension procedure
Hypovolemia, 764, 765t
in, 597
950
AClITE CARE HANDBOOK FOR PHYSICAL ll-iERAPISTS
Inconrinence--cotztitzlled
prostatitis in, 586
In cancer, 348, 349
pyelonephritis In, 572-574
physical therapy in, 600
respiratory. 6 1 8-624
types of, 585t
sepsis in, 637-638
Infarction
of skin, 630
cerebral, 3 1 3
sputum analysis in, 109, 1 1 9
myocardial, 39-43. See also Myocar·
subclinical, 607t
dium, ischemia and infarction
terminology related (0, 606, 607t
of
roxoplasmosls, 637
Infections, 605-640
in transplant recipients, 707-708
in arthroplasty, 207
In bone marrow transplantation,
resection procedure in, 207-209
735-736
bacterial. See Bacterial infections
in lung transplantation, 730
in burns, 452-453
viral. See Viral infections
cardiac, 624-625
of wounds, 482
carrier in, 607t
Inflammatory demyelinating polyradicucerebrospinal fluid analysis in, 303
lopathy, acute, 320
in chemotherapy and neutro�nia,
Inflammatory phase of wound heahng,
343
472-473
communicable, 607t
InfluenL1, 6 1 9-620
in diabetes mellitus, 6 8 1
Inhalation IIljury in burns, 450-451
disseminated, 607t
Inotropic drugs in heart failure, 59, 867t
drug therapy in, 638, 848t-850t
Inspection. See Observation and inspcc·
sensitivity and resistance to, 6 1 2 ,
tion
6 1 5� 1 8, 623
Inspir�Uion, 92-94
evaluation of, 606-61 3
auscultation In, 1 0 1 , 103
history taking in, 606
capacity in. l 22f, 1 27t
laborarory studies in, 6 1 0-613
flow rale III mechanical venrilation,
physical examination in, 607-609
8221
fungal
ratio to expiration in mechanical venhistoplasmosis in, 623-624, 635t
tilation, 822t
in rml1splanr recipients, 707, 708
reserve volume in, 1 22f, 126t
gastrointestinal, 630-63 I
Insulin in dLabetes mellitus, 674, 676t,
glomerulonephritis in, 575-576
677
host in, 607t
and hypoglycemia, 685
immune system in, 606, 608t, 609t
type 2, 678
musculoskeletal, 629-630
Integumentary system, 436(, 436-437,
neurologic, 625-629
438t. See also Skin
nosocomial, 607t, 6 1 4
Intensive care UI1I1, 757-759
antibiotic·resistant, 6 1 5-6 1 8